文献速递糖尿病

日本1型糖尿病患者中β细胞耗竭的快速与缓慢进展者及其预测因素:TIDE-J前瞻性纵向研究

Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J).
PubMed 文献 · Diabetes Care · 2025-01-01

TIDE-J全国多中心前瞻性纵向研究纳入314例日本1型糖尿病患者(急性起病型165例、缓慢进展型105例、暴发型44例),每年收集C肽、血糖控制、自身抗体等数据并分析HLA基因型,随访至多14年。结果显示不同亚型C肽不可检出率差异显著,HLA基因型与进展速度相关,缓慢进展型中低BMI、GAD抗体阳性及DR2单倍型缺失可预测进展至胰岛素依赖。

要点

  • 起病5年时C肽不可检出率:急性起病型43.1%(n=55)、缓慢进展型9.1%(n=7)、暴发型93.2%(n=38)。
  • DR4/DR4携带者β细胞耗竭较慢,DR4/DR8与DR4/DR9与快速进展相关。
  • 缓慢进展型中,低BMI、GAD抗体阳性及DR2单倍型缺失可预测进展至胰岛素依赖。

核心结论

  • 本研究阐明日本1型糖尿病患者β细胞功能障碍的异质性,并识别疾病进展的遗传与临床预测因素,为个体化管理策略和未来治疗干预提供见解。

研究设计与样本

  • 全国多中心前瞻性纵向日本1型糖尿病数据库研究(TIDE-J),纳入314例日本1型糖尿病患者,包括急性起病型165例、缓慢进展型105例和暴发型44例。
  • 每年收集C肽水平、血糖控制和自身抗体状态等临床数据,随访至多14年;研究入组时分析HLA基因型。
  • 采用生存曲线和Cox比例风险模型分析进展至胰岛素耗竭的时间,以确定预测因素。

主要发现

  • 起病5年时,C肽不可检出率在急性起病型为43.1%(n=55)、缓慢进展型为9.1%(n=7)、暴发型为93.2%(n=38)。
  • 即使在急性起病型1型糖尿病内部,向β细胞耗竭的进展也存在显著个体间差异。
  • HLA基因型影响进展速度:DRB1*04:05-DQB1*04:01/DRB1*04:05-DQB1*04:01(DR4/DR4)携带者β细胞耗竭较慢,而DR4/DRB1*08:02-DQB1*03:02(即DR4/DR8)和DR4/DRB1*09:01-DQB1*03:03(即DR4/DR9)与快速进展相关。
  • 对于缓慢进展型1型糖尿病,低BMI、GAD抗体阳性以及DRB1*15:01-DQB1*06:02或DRB1*15:02-DQB1*06:01(即DR2)单倍型缺失可预测进展至胰岛素依赖。

关键数值与推荐

  • 起病5年时C肽不可检出率:急性起病型43.1%(n=55)、缓慢进展型9.1%(n=7)、暴发型93.2%(n=38)。
  • DR4/DR4携带者β细胞耗竭较慢;DR4/DR8和DR4/DR9与快速进展相关。
  • 缓慢进展型中,低BMI、GAD抗体阳性及DR2单倍型缺失为进展至胰岛素依赖的预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to investigate the progression of β-cell dysfunction and its predictors in Japanese patients with type 1 diabetes, using data from the nationwide, multicenter, prospective longitudinal Japanese Type 1 Diabetes Database Study (TIDE-J). RESEARCH DESIGN AND METHODS: TIDE-J enrolled 314 Japanese individuals with type 1 diabetes, including 165 with acute-onset, 105 with slowly progressive, and 44 with fulminant type 1 diabetes. Clinical data, including C-peptide levels, glycemic control, and autoantibody status, were collected annually for up to 14 years. HLA genotypes were analyzed at study entry. The time to insulin depletion was analyzed using survival curves and Cox proportional hazards models to determine predictive factors. RESULTS: The rate of undetectable C-peptide varied significantly among subtypes. At 5 years after onset, 43.1% (n = 55) of patients with acute-onset, 9.1% (n = 7) with slowly progressive, and 93.2% (n = 38) with fulminant type 1 diabetes reached undetectable C-peptide. Even within acute-onset type 1 diabetes, a marked interindividual variation was observed in the progression toward β-cell depletion. HLA genotypes influenced progression rates as follows: DRB1*04:05-DQB1*04:01/DRB1*04:05-DQB1*04:01 (DR4/DR4) carriers exhibited slower β-cell depletion, whereas DR4/DRB1*08:02-DQB1*03:02 (i.e., DR4/DR8) and DR4/DRB1*09:01-DQB1*03:03 (i.e., DR4/DR9) were associated with a rapid progression. For slowly progressive type 1 diabetes, low BMI, GAD antibody positivity, and absence of the DRB1*15:01-DQB1*06:02 or DRB1*15:02-DQB1*06:01 (i.e., DR2) haplotype were predictive of progression to insulin dependence. CONCLUSIONS: This study elucidates the heterogeneity in β-cell dysfunction among Japanese individuals with type 1 diabetes and identifies genetic and clinical predictors of disease progression. These findings provide insights for individualized management strategies and future therapeutic interventions.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Noso S, Chujo D, Imagawa A, et al. Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J). Diabetes Care. 2025. PMID: 40509916. doi:10.2337/dc25-0579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。